- English
- Español
- Português
- русский
- Français
- 日本語
- Deutsch
- tiếng Việt
- Italiano
- Nederlands
- ภาษาไทย
- Polski
- 한국어
- Svenska
- magyar
- Malay
- বাংলা ভাষার
- Dansk
- Suomi
- हिन्दी
- Pilipino
- Türkçe
- Gaeilge
- العربية
- Indonesia
- Norsk
- تمل
- český
- ελληνικά
- український
- Javanese
- فارسی
- தமிழ்
- తెలుగు
- नेपाली
- Burmese
- български
- ລາວ
- Latine
- Қазақша
- Euskal
- Azərbaycan
- Slovenský jazyk
- Македонски
- Lietuvos
- Eesti Keel
- Română
- Slovenski
- मराठी
- Srpski језик
New Products
Sinae intermedia Factory
Sandoo anno 2009 stabilivit, copiam facultatis a R&D gubernatore ad scalam mercatoriam formavimus., inter API, anti-cancer, intermedia medicamenta antiviralia, oeconomiae subtilia, cibaria additiva, necnon clavis media mixtorum polypeptidorum in facie biopharmaceuticorum in mundus.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
Sandoo est unus e primoribus opificibus intermediorum in Sinis, offerens amplis qualitatem actuosam intermedia pharmaceuticas. Societas principale negotium est circiter 90% ad educendum et 10% importandum, et paulatim plus quam XX regiones in mundo obtegens. Facillime invenire potes opus quod opus est per inquisitionem nostram productam cum accuratis specificationibus per numerum et intermedia nomina CAS.
Sandoo explicant FDA probati et GMP fontes sicut nostri, constituimus et sequimur regulam qualitatis normae. Nostri centra R&D cooperata sunt sita in Shanghai, Beijing, Guangzhou, Hangzhou, nova medicamenta tegens et compositorum provectus. R&D centra valida habent R&D et innovationis facultates in processu evolutionis, processus optimiizationis et methodi analyticae evolutionis. Si alias quaestiones habes, pls contactum nos.
- View as
Uracil
Product Name: Uracil
Formulae hypotheticae: C4H4N2O2
Molecular pondus: 112.09
CAS Subcriptio Number: 66-22-8
5-Azacytosine
Product Name:5-Azacytosine
Formulae hypotheticae: C3H4N4O
Molecular pondus: 112.09
CAS Subcriptio Number:931-86-2
N4-Benzoylcytosine
Product Name:N4-Benzoylcytosine
Formulae hypotheticae: C11H9N3O2
Pondus hypotheticum: 215.21
CAS Registry Number: 26661-13-2
N4-Acetylcytosine
Product Name: N4-Acetylcytosine
Formulae hypotheticae: C6H7N3O2
Molecular pondus:153.14
CAS Subcriptio Number:14631-20-0
Cytosine
Product Name: Cytosine
Formulae hypotheticae: 4H5N3O
Molecular pondus: 111,1
CAS Subcriptio Number: 71-30-7
![4-Nitrobenzyl (2S,4S) -4-acetylthio-2-[[N-butoxycarbonyl)amino]methyl]pyrrolidine-1-sulfamoyl-N-(tert-carboxylato](/upload/6698/4-nitrobenzyl-2s-4s-4-acetylthio-2-n-butoxycarbonyl-amino-methyl-pyrrolidine-1-sulfamoyl-n-tert-carboxylate_36538.gif "4-Nitrobenzyl (2S,4S) -4-acetylthio-2-[[N-butoxycarbonyl)amino]methyl]pyrrolidine-1-sulfamoyl-N-(tert-carboxylato")
4-Nitrobenzyl (2S,4S) -4-acetylthio-2-[[N-butoxycarbonyl)amino]methyl]pyrrolidine-1-sulfamoyl-N-(tert-carboxylato
Product Name:4-nitrobenzyl(2S,4S)-4-acetylthio-2-[[N-butoxycarbonyl)amino]methyl]pyrrolidine-1-sulfamoyl-N-(tert-carboxylatum
Formulae hypotheticae: C20H28N4O9S2
Molecular pondus:532.59
CAS Subcriptio Number:491878-06-9
Sandoo magnus intermedia fabrica et praebitus in Sinis est. Officina nostra in intermedia exportare et importare plus quam 10 annos posita est, et fructus nostri toto orbe terrarum operiuntur, ut Civitates Foederatae, Canada, Britanniarum Regnum, Franciae, etc., paulatim plus quam XX operiunt. terris per orbem.
